NO863315L - Farmasoeytiske preparater bestaaende av acylerte fosfolipider. - Google Patents

Farmasoeytiske preparater bestaaende av acylerte fosfolipider.

Info

Publication number
NO863315L
NO863315L NO863315A NO863315A NO863315L NO 863315 L NO863315 L NO 863315L NO 863315 A NO863315 A NO 863315A NO 863315 A NO863315 A NO 863315A NO 863315 L NO863315 L NO 863315L
Authority
NO
Norway
Prior art keywords
appropriate
pharmaceutically acceptable
phospholipid
alkylene
atoms
Prior art date
Application number
NO863315A
Other languages
English (en)
Other versions
NO863315D0 (no
NO171886B (no
NO171886C (no
Inventor
Alan J Schroit
Rajiv Nayar
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO863315D0 publication Critical patent/NO863315D0/no
Publication of NO863315L publication Critical patent/NO863315L/no
Publication of NO171886B publication Critical patent/NO171886B/no
Publication of NO171886C publication Critical patent/NO171886C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO863315A 1985-08-19 1986-08-18 Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av en vandig dispersjon inneholdende liposomer bestaaende av fosfolipidkomponenter NO171886C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76662585A 1985-08-19 1985-08-19

Publications (4)

Publication Number Publication Date
NO863315D0 NO863315D0 (no) 1986-08-18
NO863315L true NO863315L (no) 1987-02-20
NO171886B NO171886B (no) 1993-02-08
NO171886C NO171886C (no) 1993-05-19

Family

ID=25077017

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863315A NO171886C (no) 1985-08-19 1986-08-18 Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av en vandig dispersjon inneholdende liposomer bestaaende av fosfolipidkomponenter

Country Status (18)

Country Link
EP (1) EP0213523B1 (no)
JP (1) JPS6296431A (no)
KR (1) KR870001838A (no)
AT (1) ATE59002T1 (no)
AU (1) AU591162B2 (no)
CA (1) CA1273575A (no)
DD (1) DD248736A5 (no)
DE (1) DE3676133D1 (no)
DK (1) DK165314C (no)
ES (1) ES2001099A6 (no)
FI (1) FI863311A (no)
GR (1) GR862144B (no)
HU (1) HU206045B (no)
NO (1) NO171886C (no)
NZ (1) NZ217239A (no)
PH (1) PH26160A (no)
PT (1) PT83204B (no)
ZA (1) ZA866200B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256989A1 (en) * 1986-08-18 1988-02-24 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
DK86988A (da) * 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd Liposompraeparat og anvendelse deraf
AU7496991A (en) * 1990-03-20 1991-10-21 Otsuka Pharmaceutical Co., Ltd. Liposome preparation
DK0699068T3 (da) * 1993-05-21 2002-03-11 Liposome Co Inc Reduktion af liposominducerede fysiologiske bivirkninger
DK0785773T3 (da) * 1994-10-14 2001-01-29 Liposome Co Inc Etherlipidliposomer og deres terapeutiske anvendelse
US6589503B1 (en) 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US8038984B2 (en) 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US7306784B2 (en) 1998-06-20 2007-12-11 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
WO2006026184A2 (en) 2004-08-20 2006-03-09 Washington University Blood brain barrier permeation peptides
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20200197547A1 (en) 2017-08-30 2020-06-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-mesothelin radiolabelled single domain antibodies suitable for the imaging and treatment of cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3218027A1 (de) * 1982-05-13 1983-11-17 A. Nattermann & Cie GmbH, 5000 Köln Phospholipidloesungen

Also Published As

Publication number Publication date
PH26160A (en) 1992-03-18
NZ217239A (en) 1989-09-27
ES2001099A6 (es) 1988-04-16
HU206045B (en) 1992-08-28
DE3676133D1 (de) 1991-01-24
CA1273575A (en) 1990-09-04
PT83204B (pt) 1989-03-30
FI863311A (fi) 1987-02-20
EP0213523A2 (de) 1987-03-11
JPS6296431A (ja) 1987-05-02
EP0213523B1 (de) 1990-12-12
FI863311A0 (fi) 1986-08-15
AU6155686A (en) 1987-02-26
NO863315D0 (no) 1986-08-18
DD248736A5 (de) 1987-08-19
HUT41634A (en) 1987-05-28
DK165314B (da) 1992-11-09
NO171886B (no) 1993-02-08
DK392786D0 (da) 1986-08-18
EP0213523A3 (en) 1987-10-14
PT83204A (en) 1986-09-01
AU591162B2 (en) 1989-11-30
ZA866200B (en) 1987-03-25
DK165314C (da) 1993-03-29
KR870001838A (ko) 1987-03-28
GR862144B (en) 1986-12-23
DK392786A (da) 1987-02-20
ATE59002T1 (de) 1990-12-15
NO171886C (no) 1993-05-19

Similar Documents

Publication Publication Date Title
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
NO863315D0 (no) Farmasoeytiske preparater bestaaende av acylerte fosfolipider.
NZ223262A (en) 11-arylestra-4,9-dien-3-ones, derivatives and pharmaceutical compositions
ES514240A0 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
NO178923C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 24-homo-vitamin-D-derivater
FR2649110B1 (fr) Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FI834702A (fi) Nya nitroalifatiska foereningar, deras framstaellningsfoerfarande och anvaendning.
IL87254A0 (en) Stable oxapenem-3-carboxylic acids,their preparation and pharmaceutical compositions containing them
DK627987A (da) Farmaceutiske praeparater
ES8207538A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilicos 6-, 1- y 2-sustituidos.
ES2087421T3 (es) Acidos (1's)-hidroxialquiloxapenem-3-carboxilicos y su uso como inhibidor de la betalactamasa.
RU94042399A (ru) Получения клавулановой кислоты из соли клавулановой кислоты и амина, соли клавулановой кислоты и амина
PT86422A (fr) Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant